News Detail
Maryland, 23 Jan 2024: The U.S. health regulator said on Monday companies will be required to add a serious warning on the prescribing information for cancer therapies known as CAR-T, made by Gilead Sciences, Johnson & Johnson, Novartis and others.
Source : Reuters
cancer therapies
CAR-T
serious warning
Gilead Sciences
Johnson & Johnson
 NovartisÂ
Related News
- Stent not Removed After PCNL: Hospital, surgeon Slapped Rs 35 Lakh Compensation for Deficiency in Service (05-11-2024)
- Philippines: Fake child vitamins 'produced in washing machine' (05-11-2024)
- CDSCO may regulate health supplements (05-11-2024)
- Malda: 2,400 bottles of phensedyl seized (05-11-2024)
- US Court blocks Sun Pharma's LEQSELVI launch, Grants preliminary injunction amid patent dispute (04-11-2024)
- Ayush Ministry amends Rules to mandate renewal of licenses perpetuity (04-11-2024)
- Procedural lapse in NDPS cases can violate fundamental rights: High Court (04-11-2024)
- FSSAI sets stricter rule for antibiotics in food items (04-11-2024)
- Pregnant woman suffered ruptured uterus and blood turned toxic after pills, RMP under lens (04-11-2024)
- Dr Reddy’s recalls over 3 lakh bottles of Cinacalcet tablets in US due to manufacturing issues (03-11-2024)